Characteristics of elderly patients with COPD and newly diagnosed lung cancer, and factors associated with treatment decision

International Journal of COPD

Volumn 11, Issue 1, 2016, Pages 1515-1520

  Qin, Jianwen ^a   Li, Guangsheng ^a   Zhou, Jingmin ^a  

^a Tianjin Chest Hospital   (China)

Author keywords

Chronic obstructive pulmonary disease; Diagnosis; Lung cancer; Treatment

Indexed keywords

CORTICOSTEROID; ANTINEOPLASTIC AGENT; BRONCHODILATING AGENT;

ADULT; AGED HOSPITAL PATIENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CHINESE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; NONHUMAN; RETROSPECTIVE STUDY; SMALL CELL LUNG CANCER; SMOKING; SQUAMOUS CELL LUNG CARCINOMA; ADENOCARCINOMA; ADVERSE EFFECTS; AGE; AGED; CANCER GRADING; CARCINOMA, SQUAMOUS CELL; CHINA; CLINICAL DECISION MAKING; DRUG EFFECTS; HEALTH STATUS; LUNG; LUNG NEOPLASMS; LUNG RESECTION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT SELECTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; SMALL CELL LUNG CARCINOMA; STATISTICAL MODEL; SURGERY; TREATMENT OUTCOME;

ADENOCARCINOMA; ADRENAL CORTEX HORMONES; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; BRONCHODILATOR AGENTS; CARCINOMA, SQUAMOUS CELL; CHINA; CLINICAL DECISION-MAKING; FEMALE; HEALTH STATUS; HUMANS; LOGISTIC MODELS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; ODDS RATIO; PATIENT SELECTION; PNEUMONECTOMY; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS; SMALL CELL LUNG CARCINOMA; SMOKING; TREATMENT OUTCOME;

EID: 84978945717     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S104670     Document Type: Article

References (27)

1. Qaseem A, Wilt TJ, Weinberger SE, et al; American College of Physicians, American College of Chest Physicians, American Thoracic Society, European Respiratory Society. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011; 155(3): 179-191.
2. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013; 187(4): 347-365.
3. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003; 123(5): 1684-1692.
4. Buist AS, McBurnie MA, Vollmer WM, et al; BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370(9589): 741-750.
5. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014; 64(1): 9-29.
6. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5 suppl): 78S-92S.
7. de Torres JP, Bastarrika G, Wisnivesky JP, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest. 2007; 132(6): 1932-1938.
8. Mayne ST, Buenconsejo J, Janerich DT. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol. 1999; 149(1): 13-20.
9. de Torres JP, Marín JM, Casanova C, et al. Lung cancer in patients with chronic obstructive pulmonary disease-incidence and predicting factors. Am J Respir Crit Care Med. 2011; 184(8): 913-919.
10. Raviv S, Hawkins KA, DeCamp MM Jr, Kalhan R. Lung cancer in chronic obstructive pulmonary disease: enhancing surgical options and outcomes. Am J Respir Crit Care Med. 2011; 183(9): 1138-1146.
11. Schroedl C, Kalhan R. Incidence, treatment options, and outcomes of lung cancer in patients with chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2012; 18(2): 131-137.
12. Kiri VA, Soriano J, Visick G, Fabbri L. Recent trends in lung cancer and its association with COPD: an analysis using the UK GP research database. Prim Care Respir J. 2010; 19(1): 57-61.
13. Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol. 2005; 40(2): 90-97.
14. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med. 2009; 360(23): 2445-2454.
15. Zhang H, Cai B. The impact of tobacco on lung health in China. Respirology. 2003; 8(1): 17-21.
16. Celli B, Decramer M, Kesten S, et al; UPLIFT Study Investigators. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009; 180(10): 948-955.
17. Calverley PM, Anderson JA, Celli B, et al; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007; 356(8): 775-789.
18. Vestbo J, Anderson W, Coxson HO, et al; ECLIPSE investigators. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J. 2008; 31(4): 869-873.
19. Tsushima K, Sone S, Fujimoto K, et al. Identification of occult parechymal disease such as emphysema or airway disease using screening computed tomography. COPD. 2010; 7(2): 117-125.
20. Gullón JA, Suárez I, Medina A, Rubinos G, Fernández R, González I. Role of emphysema and airway obstruction in prognosis of lung cancer. Lung Cancer. 2011; 71(2): 182-185.
21. Papi A, Casoni G, Caramori G, et al. COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax. 2004; 59(8): 679-681.
22. National Lung Screening Trial Research Team; Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5): 395-409.
23. de-Torres JP, Wilson DO, Sanchez-Salcedo P, et al. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD lung cancer screening score. Am J Respir Crit Care Med. 2015; 191(3): 285-291.
24. Parimon T, Chien JW, Bryson CL, McDonell MB, Udris EM, Au DH. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007; 175(7): 712-719.
25. Hashimoto N, Matsuzaki A, Okada Y, et al. Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients. BMC Pulm Med. 2014; 14: 14.
26. Palma D, Lagerwaard F, Rodrigues G, Haasbeek C, Senan S. Curative treatment of stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys. 2012; 82(3): 1149-1156.
27. McGarry RC, Song G, des Rosiers P, Timmerman R. Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest. 2002; 121(4): 1155-1158.